Safety and usage of darbepoetin alfa in children with chronic kidney disease: prospective registry study

Limited prospective data are available on the long-term safety of darbepoetin alfa (DA) for treating anemia in children with chronic kidney disease (CKD).

Saved in:

Bibliographic Details
Main Authors:	Schaefer, Franz (Author) , Hoppe, Bernd (Author) , Jungraithmayr, Therese (Author) , Klaus, Günter (Author) , Pape, Lars (Author) , Farouk, Mourad (Author) , Addison, Janet (Author) , Manamley, Nick (Author) , Vondrak, Karel (Author)
Format:	Article (Journal)
Language:	English
Published:	2016
In:	Pediatric nephrology Year: 2015, Volume: 31, Issue: 3, Pages: 443-453
ISSN:	1432-198X
DOI:	10.1007/s00467-015-3225-0
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00467-015-3225-0 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007%2Fs00467-015-3225-0
Author Notes:	Franz Schaefer, Bernd Hoppe, Therese Jungraithmayr, Günter Klaus, Lars Pape, Mourad Farouk, Janet Addison, Nick Manamley, Karel Vondrak

Description
Summary:	Limited prospective data are available on the long-term safety of darbepoetin alfa (DA) for treating anemia in children with chronic kidney disease (CKD).
Item Description:	Published online: 19 October 2015 Gesehen am 12.05.2020
Physical Description:	Online Resource
ISSN:	1432-198X
DOI:	10.1007/s00467-015-3225-0